These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 28389156

  • 1. Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.
    Fabbri M, Coelho M, Guedes LC, Chendo I, Sousa C, Rosa MM, Abreu D, Costa N, Godinho C, Antonini A, Ferreira JJ.
    Parkinsonism Relat Disord; 2017 Jun; 39():37-43. PubMed ID: 28389156
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson's Disease.
    Rosqvist K, Odin P, Hagell P, Iwarsson S, Nilsson MH, Storch A.
    J Parkinsons Dis; 2018 Jun; 8(3):409-420. PubMed ID: 30056433
    [Abstract] [Full Text] [Related]

  • 5. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
    Rosqvist K, Horne M, Hagell P, Iwarsson S, Nilsson MH, Odin P.
    J Parkinsons Dis; 2018 Jun; 8(1):59-70. PubMed ID: 29480220
    [Abstract] [Full Text] [Related]

  • 6. Dysphagia predicts poor outcome in late-stage Parkinson's disease.
    Fabbri M, Coelho M, Abreu D, Guedes LC, Rosa MM, Godinho C, Cardoso R, Guimaraes I, Antonini A, Zibetti M, Lopiano L, Ferreira JJ.
    Parkinsonism Relat Disord; 2019 Jul; 64():73-81. PubMed ID: 30902528
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U, Kaldonska M, Klodowska-Duda G, Wyska E, Safranow K, Bialecka M, Gawronska-Szklarz B.
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [Abstract] [Full Text] [Related]

  • 8. ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.
    Faggianelli F, Witjas T, Azulay JP, Benatru I, Hubsch C, Anheim M, Moreau C, Hainque E, Drapier S, Jarraya B, Laurencin C, Guehl D, Hopes L, Brefel-Courbon C, Tir M, Marques A, Rouaud T, Maltete D, Giordana C, Baumstarck K, Rascol O, Corvol JC, Rolland AS, Devos D, Eusebio A, PREDISTIM study group.
    J Neurol Neurosurg Psychiatry; 2024 Jun 17; 95(7):656-662. PubMed ID: 38272656
    [Abstract] [Full Text] [Related]

  • 9. Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease.
    Fabbri M, Guimarães I, Cardoso R, Coelho M, Guedes LC, Rosa MM, Godinho C, Abreu D, Gonçalves N, Antonini A, Ferreira JJ.
    Front Neurol; 2017 Jun 17; 8():432. PubMed ID: 28878734
    [Abstract] [Full Text] [Related]

  • 10. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C.
    Mov Disord; 2013 Nov 17; 28(13):1838-46. PubMed ID: 23853029
    [Abstract] [Full Text] [Related]

  • 11. Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.
    Cova I, Di Battista ME, Vanacore N, Papi CP, Alampi G, Rubino A, Valente M, Meco G, Contri P, Di Pucchio A, Lacorte E, Priori A, Mariani C, Pomati S.
    Parkinsonism Relat Disord; 2017 Jan 17; 34():38-42. PubMed ID: 28029554
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson's disease.
    Witt K, Daniels C, Herzog J, Lorenz D, Volkmann J, Reiff J, Mehdorn M, Deuschl G, Krack P.
    J Neuropsychiatry Clin Neurosci; 2006 Jan 17; 18(3):397-401. PubMed ID: 16963590
    [Abstract] [Full Text] [Related]

  • 13. Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease.
    Arena JE, Cerquetti D, Rossi M, Chaves H, Rollan C, Dossi DE, Merello M.
    Parkinsonism Relat Disord; 2016 Mar 17; 24():126-8. PubMed ID: 26823237
    [Abstract] [Full Text] [Related]

  • 14. When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease?
    De Luka SR, Svetel M, Pekmezović T, Milovanović B, Kostić VS.
    Vojnosanit Pregl; 2014 Apr 17; 71(4):346-51. PubMed ID: 24783414
    [Abstract] [Full Text] [Related]

  • 15. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease.
    Gierthmühlen J, Arning P, Binder A, Herzog J, Deuschl G, Wasner G, Baron R.
    Mov Disord; 2010 Jul 15; 25(9):1195-202. PubMed ID: 20629160
    [Abstract] [Full Text] [Related]

  • 16. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
    Lees AJ, Tolosa E, Olanow CW.
    Mov Disord; 2015 Jan 15; 30(1):19-36. PubMed ID: 25488030
    [Abstract] [Full Text] [Related]

  • 17. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T, Uchiyama T, Higuchi Y, Asahina M, Hirano S, Yamanaka Y, Kuwabara S.
    PLoS One; 2015 Jan 15; 10(9):e0138462. PubMed ID: 26394059
    [Abstract] [Full Text] [Related]

  • 18. Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients.
    Pérez-Pérez J, Pagonabarraga J, Martínez-Horta S, Fernández-Bobadilla R, Sierra S, Pascual-Sedano B, Gironell A, Kulisevsky J.
    Drugs Aging; 2015 May 15; 32(5):401-7. PubMed ID: 25941103
    [Abstract] [Full Text] [Related]

  • 19. Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease.
    Verhagen Metman L, Stover N, Chen C, Cowles VE, Sweeney M.
    Mov Disord; 2015 Aug 15; 30(9):1222-8. PubMed ID: 25847690
    [Abstract] [Full Text] [Related]

  • 20. Fatigue in levodopa-naive subjects with Parkinson disease.
    Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S, Parkinson Study Group ELLDOPA Investigators.
    Neurology; 2008 Aug 12; 71(7):481-5. PubMed ID: 18695158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.